PORTLAND, Ore., Jan. 11, 2021 /PRNewswire/
-- ScanlanKemperBard (SKB), General Partner of PW Venture
Portland Limited Partnership, which is the owner of ParkWorks
Industry Center, is pleased to announce its new lease agreement
with Twist Bioscience Corporation ("Twist"), a synthetic biology
and genomics company. Twist (NASDAQ: TWST) has signed a 110,000 SF
lease at ParkWorks Industry Center in Wilsonville, Oregon, formerly known as Parkway
Woods Business Center.
SKB was represented in the transaction by Kidder Mathews and Twist was represented by
Hughes Marino and Cresa. The Twist lease is the first executed
lease since SKB's acquisition of the property in April 2020.
While Twist is constructing its tenant improvements to the
space, SKB will continue to implement its comprehensive capital
improvement plan, which includes adding grade and dock-high loading
docks around the property, opening ceiling clear heights to nearly
20 feet, constructing additional storefronts, renovating the
courtyard and adding parking throughout. With completion of the
improvements, SKB anticipates an increased interest from life
science, tech-manufacturing, and R&D tenants.
According to SKB President Todd
Gooding, "We are thrilled to welcome Twist to the ParkWorks
Industry Center, as well as the Portland market, and feel that they will be a
great addition to our tenant base at the property." Todd Gooding added, "We have spent the last two
years putting ourselves in a position to grow the life science
community in the Portland Metro
Area and we hope this transaction elevates Portland's profile as a life science
market."
About ScanlanKemperBard
SKB is an established real estate developer and operator based
in Portland, Oregon. Since its
inception in 1993, SKB has originated total portfolio activity of
$4.68 billion, comprised of 30.3
million square feet of office, industrial and retail space and
2,154 residential units. With longstanding relationships in each of
its markets, SKB has the ability to source, structure and execute
value creation across a wide spectrum of real estate opportunities.
Visit SKB online at www.skbcos.com to learn more.
About Twist Bioscience
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by "writing" DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research. Visit
Twist online at www.twistbioscience.com to learn more.
MEDIA CONTACTS
Todd Gooding
503-201-6800
View original content to download
multimedia:http://www.prnewswire.com/news-releases/skb-finalizes-new-lease-agreement-with-twist-bioscience-corporation-twist-at-recently-repositioned-mixed-use-campus-parkworks-industrial-center-301205689.html
SOURCE SKB